Filing Details
- Accession Number:
- 0001127602-24-004982
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-14 14:23:30
- Reporting Period:
- 2024-02-13
- Accepted Time:
- 2024-02-14 14:23:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591313 | R John Desjarlais | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | Sr. Vice President & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-13 | 68,057 | $11.05 | 215,783 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-02-13 | 54,108 | $19.38 | 161,675 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-13 | 68,057 | $0.00 | 68,057 | $11.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,943 | 2024-02-20 | No | 4 | M | Direct |
Footnotes
- This transaction is pursuant to a 10b5-1 plan.
- Underlying option due to expire in February 2024.
- Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
- 25% of the shares subject to the option shall vest on the one year anniversary of February 21, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.